Company & Sponsor Intelligence
Oslo University Hospital
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials4
Recruiting2
Completed1
Countries1
Therapeutic footprint
adhdintellectual_disabilityneuro_oncologyout_of_scope
Indexed studies
NCT05049356Symptoms and Mechanisms of Child Psychiatric Disorders
adhd · NorwayUNKNOWN
adhd · NorwayUNKNOWN
NCT05190172PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmas
neuro_oncology · NorwayNA
neuro_oncology · NorwayNA
NCT03768674Extreme Challenges - Psychopathology & Treatment Experiences Among Severly Selfharming Inpatients in Norway
intellectual_disability · NorwayCOMPLETED
intellectual_disability · NorwayCOMPLETED
NCT05218785Treatment of Gastrocnemius Tightness and Subsequent Chronic Plantar Fasciitis with Botulinum Toxin a
out_of_scope · NorwayRECRUITING
out_of_scope · NorwayRECRUITING
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →